95 related articles for article (PubMed ID: 2078409)
1. A bioassay for HIV-1 based on Env-CD4 interaction.
Ciminale V; Felber BK; Campbell M; Pavlakis GN
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1281-7. PubMed ID: 2078409
[TBL] [Abstract][Full Text] [Related]
2. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
3. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Xiao X; Kinter A; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
[TBL] [Abstract][Full Text] [Related]
4. Productive infection and subsequent interaction of CD4-gp120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cells.
Corbeil J; Richman DD
J Gen Virol; 1995 Mar; 76 ( Pt 3)():681-90. PubMed ID: 7897356
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the cytopathicity (fusion/hemifusion) of patient-derived HIV-1 envelope glycoproteins comparing two effector cell lines.
Cunyat F; Curriu M; Marfil S; García E; Clotet B; Blanco J; Cabrera C
J Biomol Screen; 2012 Jul; 17(6):727-37. PubMed ID: 22427259
[TBL] [Abstract][Full Text] [Related]
6. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
Raja NU; Vincent MJ; Jabbar MA
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
[TBL] [Abstract][Full Text] [Related]
7. [A non-infectious and quantitative cell-based bioassay for screening HIV entry inhibitors targeting HIV envelope proteins].
Li MM; Xia CL; Mao QC; Jiang SB; Liu SW
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):941-4. PubMed ID: 20501362
[TBL] [Abstract][Full Text] [Related]
8. Synthetic peptides allow discrimination of structural features of CD4(81-92) important for HIV-1 infection versus HIV-1-induced syncytium formation.
Lifson JD; Rausch DM; Kalyanaraman VS; Hwang KM; Eiden LE
AIDS Res Hum Retroviruses; 1991 Jun; 7(6):521-7. PubMed ID: 1931230
[TBL] [Abstract][Full Text] [Related]
9. A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.
Jiang A; Fisher H; Pomerantz RJ; Dornburg R
Hum Gene Ther; 1999 Nov; 10(16):2627-36. PubMed ID: 10566890
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of a nonsyncytium inducer HIV-1 glycoprotein inhibits syncytium formation by another HIV-1 Env protein.
Li YY; O'Donnell MA; Perez LG
Virology; 1996 Jan; 215(2):197-202. PubMed ID: 8560767
[TBL] [Abstract][Full Text] [Related]
11. CD4 confers susceptibility to human immunodeficiency virus type 1 infection in a rat fibroblast cell line.
Mizrachi Y; Rubinstein A; Golodner M; Sakai K; Volsky DJ
AIDS Res Hum Retroviruses; 1996 Sep; 12(14):1315-8. PubMed ID: 8891110
[TBL] [Abstract][Full Text] [Related]
12. Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.
Cucchiarini M; Cagnon L; Giordanengo V; Doglio A; Lefebvre JC
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):427-36. PubMed ID: 7697438
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Celada F; Düzgüneş N
J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
[TBL] [Abstract][Full Text] [Related]
14. Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion.
Xiao X; Norwood D; Feng YR; Moriuchi M; Jones-Trower A; Stantchev TS; Moriuchi H; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):139-46. PubMed ID: 10816382
[TBL] [Abstract][Full Text] [Related]
15. Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes.
Dimitrov DS; Golding H; Blumenthal R
AIDS Res Hum Retroviruses; 1991 Oct; 7(10):799-805. PubMed ID: 1742075
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Düzgünes N
Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
[TBL] [Abstract][Full Text] [Related]
17. An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120.
Alam SM; Paleos CA; Liao HX; Scearce R; Robinson J; Haynes BF
AIDS Res Hum Retroviruses; 2004 Aug; 20(8):836-45. PubMed ID: 15320988
[TBL] [Abstract][Full Text] [Related]
18. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
Otteken A; Voss G; Hunsmann G
Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
[TBL] [Abstract][Full Text] [Related]
19. Syncytium formation induced by human immunodeficiency virus type 1 isolates correlates with affinity for CD4.
Watkins BA; Crowley R; Davis AE; Louie AT; Reitz MS
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2513-22. PubMed ID: 9349472
[TBL] [Abstract][Full Text] [Related]
20. The role of CD4 in HIV binding and entry.
Sattentau QJ; Moore JP
Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):59-66. PubMed ID: 7904348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
